Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 276 clinical trials
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

This randomized phase II trial studies how well obinutuzumab works as maintenance treatment in patients with central nervous system lymphoma who have achieved the disappearance of all signs of

  • 0 views
  • 25 Jan, 2022
  • 9 locations
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries, representing approximately 30% of all adult leukemias. There is a large difference in proportion of malignant

chronic lymphocytic leukemia
lymphoma
obinutuzumab
venetoclax
ibrutinib
  • 0 views
  • 08 Jan, 2022
  • 8 locations
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

pruritus in patients with the mycosis fungoides (MF) or Szary syndrome (SS) Forms of Cutaneous T-cell Lymphoma (CTCL). This study will also determine if there is systemic absorption of the drug in a subset

skin biopsy
mycosis
naloxone hydrochloride
hysterectomy
lymphoma
  • 0 views
  • 26 Jan, 2022
  • 19 locations
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT (HCTDiet)

The purpose of this study is to see whether hematopoietic stem cell transplant (HSCT) patients can consistently eat a diet rich in prebiotics. This type of diet may be helpful in maintaining diversity in the gastrointestinal (GI) system and therefore potentially decreasing risk of other GI problems.

transplant conditioning
  • 3 views
  • 26 Jan, 2022
  • 1 location
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Background Researchers want to develop better ways to treat cancer. In this study, they will give people with cancer two drugs. These drugs have been used on their own to treat some blood cell cancers. Objectives To test the safety and efficacy of the drug combination of bortezomib and clofarabine. …

bortezomib
primary cancer
solid tumour
clofarabine
neutrophil count
  • 25 views
  • 05 Jan, 2022
  • 1 location
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

This phase I trial studies the side effects of huJCAR014 in treating patients with relapsed or refractory B-cell non-Hodgkin lymphoma or acute lymphoblastic leukemia. huJCAR014 CAR-T cells are

hodgkin's disease
cell therapy
PCR test
immunohistochemistry
fludarabine
  • 20 views
  • 12 Jan, 2022
  • 1 location
Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

This phase II trial studies how well venetoclax and ibrutinib work in treating patients with chronic or small lymphocytic leukemia. Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Ibrutinib may stop the growth of cancer cells by blocking some of …

platelet count
thrombocytopenia
lymphoid leukemia
direct bilirubin
venetoclax
  • 0 views
  • 26 Jan, 2022
  • 1 location
A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat

This is a phase I, multi-center, open-label, multi-dose, two-part PK and safety study to characterize the DDI potential of oral Tazemetostat.

kaposi's sarcoma
systemic therapy
b-cell lymphoma
renal function tests
rifampin
  • 0 views
  • 12 Jan, 2022
  • 7 locations
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

fungoides or Sezary syndrome types of T-cell lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Magrolimab and mogamulizumab are monoclonal antibodies that may interfere

anticancer agents
systemic therapy
monoclonal antibodies
neutrophil count
chemotherapy regimen
  • 2 views
  • 09 Jan, 2022
  • 3 locations
Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

The clinical study will assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid tumor malignancies or lymphoma.

  • 21 views
  • 28 Dec, 2021
  • 12 locations